Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Margolis

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
The Prostate|January 5, 2022
Pilot study of the diagnostic utility of <sup>89</sup> Zr-df-IAB2M and <sup>68</sup> Ga-PSMA-11 PET imaging and multiparametric MRI in localized prostate cancerPanagiotis J Vlachostergios, Muhammad J Niaz, Charlene Thomas, et al.
Molecular Imaging and Biology|March 17, 2004
Conventional imaging and 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of patients with previously treated Hodgkin's diseaseJean-Emmanuel Filmont, Cecelia S Yap, Fred Ko, et al.
Radiology|May 16, 2019
Components of Radiologic Progressive Disease Defined by RECIST 1.1 in Patients with Metastatic Clear Cell Renal Cell CarcinomaHeidi J Coy, Michael L Douek, Kathleen Ruchalski, et al.
Cancers|June 19, 2024
Reasons for Discordance between <sup>68</sup>Ga-PSMA-PET and Magnetic Resonance Imaging in Men with Metastatic Prostate CancerJade Wang, Elisabeth O'Dwyer, Juana Martinez Zuloaga, et al.
Molecular Imaging and Biology|September 23, 2003
Conventional imaging and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of previously treated non-Hodgkin's lymphoma patientsJean-Emmanuel Filmont, Duska Vranjesevic, Andrew Quon, et al.
The Journal of Urology|May 6, 2014
Magnetic resonance imaging-ultrasound fusion biopsy for prediction of final prostate pathologyJesse D Le, Samuel Stephenson, Michelle Brugger, et al.
Radiology|November 19, 2016
In-Bore 3-T MR-guided Transrectal Targeted Prostate Biopsy: Prostate Imaging Reporting and Data System Version 2-based Diagnostic Performance for Detection of Prostate CancerNelly Tan, Wei-Chan Lin, Pooria Khoshnoodi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 18, 2025
PURE-MRI: An international study assessing physician accuracy in delineating the prostate and urethra on prostate MRILily Nguyen, Yuze Song, Anna Dornisch, et al.
AJR. American Journal of Roentgenology|October 2, 2024
Quantitative Prostate MRI, From the <i>AJR</i> Special Series on Quantitative ImagingDaniel J A Margolis, Aritrick Chatterjee, Nandita M deSouza, et al.
AJR. American Journal of Roentgenology|May 1, 2019
Utility of Restriction Spectrum Imaging Among Men Undergoing First-Time Biopsy for Suspected Prostate CancerEly R Felker, Steven S Raman, Sepideh Shakeri, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
The Prostate|January 5, 2022
Pilot study of the diagnostic utility of <sup>89</sup> Zr-df-IAB2M and <sup>68</sup> Ga-PSMA-11 PET imaging and multiparametric MRI in localized prostate cancerPanagiotis J Vlachostergios, Muhammad J Niaz, Charlene Thomas, et al.
Molecular Imaging and Biology|March 17, 2004
Conventional imaging and 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of patients with previously treated Hodgkin's diseaseJean-Emmanuel Filmont, Cecelia S Yap, Fred Ko, et al.
Radiology|May 16, 2019
Components of Radiologic Progressive Disease Defined by RECIST 1.1 in Patients with Metastatic Clear Cell Renal Cell CarcinomaHeidi J Coy, Michael L Douek, Kathleen Ruchalski, et al.
Cancers|June 19, 2024
Reasons for Discordance between <sup>68</sup>Ga-PSMA-PET and Magnetic Resonance Imaging in Men with Metastatic Prostate CancerJade Wang, Elisabeth O'Dwyer, Juana Martinez Zuloaga, et al.
Molecular Imaging and Biology|September 23, 2003
Conventional imaging and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of previously treated non-Hodgkin's lymphoma patientsJean-Emmanuel Filmont, Duska Vranjesevic, Andrew Quon, et al.
The Journal of Urology|May 6, 2014
Magnetic resonance imaging-ultrasound fusion biopsy for prediction of final prostate pathologyJesse D Le, Samuel Stephenson, Michelle Brugger, et al.
Radiology|November 19, 2016
In-Bore 3-T MR-guided Transrectal Targeted Prostate Biopsy: Prostate Imaging Reporting and Data System Version 2-based Diagnostic Performance for Detection of Prostate CancerNelly Tan, Wei-Chan Lin, Pooria Khoshnoodi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 18, 2025
PURE-MRI: An international study assessing physician accuracy in delineating the prostate and urethra on prostate MRILily Nguyen, Yuze Song, Anna Dornisch, et al.
AJR. American Journal of Roentgenology|October 2, 2024
Quantitative Prostate MRI, From the <i>AJR</i> Special Series on Quantitative ImagingDaniel J A Margolis, Aritrick Chatterjee, Nandita M deSouza, et al.
AJR. American Journal of Roentgenology|May 1, 2019
Utility of Restriction Spectrum Imaging Among Men Undergoing First-Time Biopsy for Suspected Prostate CancerEly R Felker, Steven S Raman, Sepideh Shakeri, et al.
Pageof 10